Limburg Ventures logo

Limburg Ventures

Europe, Limburg, The Netherlands, Maastricht

Description

Limburg Ventures is a dedicated regional venture capital fund operating out of Maastricht, The Netherlands, with a primary mission to foster innovation and economic growth within the province of Limburg. Managed by LIOF, the Limburg Development Company, the fund strategically targets early-stage and growth companies, particularly those operating in the life sciences, advanced chemicals, and materials sectors. Beyond these core areas, Limburg Ventures also extends its investment scope to include high-tech manufacturing, logistics, and other innovative industries that demonstrate significant growth potential and contribute to the regional ecosystem. Its focus is on companies with strong intellectual property, scalable business models, and experienced management teams.

The fund's investment strategy is characterized by its commitment to supporting companies from seed to Series A stages, often providing crucial early-stage capital. Limburg Ventures typically provides initial equity investments ranging from approximately €250,000 to €1.5 million per company. This initial commitment is often followed by subsequent rounds, with the potential for total investments per company to reach up to €5 million, demonstrating a long-term partnership approach. The most recent iteration, Limburg Ventures III, launched in 2021, boasts a fund size of €30 million, underscoring its capacity to make substantial contributions to the regional startup landscape.

As an integral part of the Limburg innovation ecosystem, Limburg Ventures plays a pivotal role in bridging the funding gap for promising local startups and scale-ups. Its close ties with LIOF provide portfolio companies with access to a broader network of resources, including business development support, strategic guidance, and connections to industry experts. The fund's localized approach ensures a deep understanding of the regional market dynamics and specific needs of companies based in Limburg, making it a key financial partner for entrepreneurs aiming to develop and scale their ventures within the region.

Investor Profile

Limburg Ventures has backed more than 22 startups, with 0 new investments in the last 12 months alone. The firm has led 9 rounds, about 41% of its total and boasts 7 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A, Undisclosed rounds (top funding stages).
  • Majority of deals are located in The Netherlands, Germany, France.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Typical check size: $270K – $1.6M.

Stage Focus

  • Series Unknown (41%)
  • Series A (14%)
  • Undisclosed (14%)
  • Series B (14%)
  • Seed (9%)
  • Series C (5%)
  • Private Equity (5%)

Country Focus

  • The Netherlands (77%)
  • Germany (9%)
  • France (5%)
  • United Kingdom (5%)
  • Belgium (5%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Manufacturing
  • Genetics
  • Life Science
  • Nanotechnology
  • Therapeutics
  • Chemical
  • Energy Efficiency
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Limburg Ventures frequently co-invest with?

LS
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Thuja Capital
Europe, Utrecht, The Netherlands, Utrecht
Co-Investments: 2
NH
Europe, Limburg, The Netherlands, Maastricht
Co-Investments: 5
NV Industriebank LIOF
Europe, Limburg, The Netherlands, Maastricht
Co-Investments: 5
M
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Limburgse Reconversie Maatschappij
Europe, Limburg, Belgium, Hasselt
Co-Investments: 1
DSM Venturing
Europe, Limburg, The Netherlands, Heerlen
Co-Investments: 1
SHIFT Invest
Europe, Noord-Holland, The Netherlands, Amstelveen
Co-Investments: 1
Chemelot Ventures
Europe, Limburg, The Netherlands, Urmond
Co-Investments: 3
HI
North America, California, United States, Oakland
Co-Investments: 2

Which angels does Limburg Ventures often collaborate with?

JM
Europe, Guernsey
Shared Deals: 1
SH
Europe, England, United Kingdom, London
Shared Deals: 1
KP
Europe, England, United Kingdom, London
Shared Deals: 1
EK
Europe, Limburg, The Netherlands, Maastricht
Shared Deals: 1
HV
Europe, Limburg, The Netherlands, Maastricht
Shared Deals: 1

What are some of recent deals done by Limburg Ventures?

ReSolved Technologies

Sittard, Limburg, The Netherlands

ReSolved Technologies are dedicated to increase the circularity of engineering plastics by addressing complex waste streams.

RecyclingWaste Management
SeedAug 30, 2023
Amount Raised: $1,092,952
Kriya Materials

Geleen, Limburg, The Netherlands

Kriya Materials is the innovative developer and manufacturer of various metal oxide nano particles.

Energy EfficiencyNanotechnology
Series ASep 13, 2017
Amount Raised: $3,566,334
FABPulous

Maastricht, Limburg, The Netherlands

FABPulous is an innovative healthcare company which develops and markets solutions for diagnostics in primary care and emergency medicine.

BiotechnologyHealth CareMedicalPrimary and Urgent Care
Series BFeb 4, 2015
Amount Raised: $2,040,000
Enzypep

Geleen, Limburg, The Netherlands

Enzypep designs and develops oligopeptides for pharmaceutical products.

BiotechnologyGeneticsHealth CareLife ScienceManufacturing
UndisclosedJan 1, 2014
Ekompany

Born, Limburg, The Netherlands

Ekompany is a Dutch producer of coated mineral fertilisers (CRF) with sales operations in Western Europe and Far East.

AgricultureChemicalEnergy EfficiencyManufacturing
Series UnknownMar 6, 2013
Amount Raised: $14,547,930
Mirnext

Amsterdam, Noord-Holland, The Netherlands

Mirnext focuses on the discovery, validation, and commercialization of miRNAs as novel biomarkers for cardiovascular disease.

BiotechnologyGeneticsHealth CareLifestylePharmaceuticalTherapeutics
Series UnknownJan 1, 2012
BioActor

Maastricht, Limburg, The Netherlands

BioActor develops proprietary health ingredients for use in functional foods, medical nutrition, and dietary supplements.

BiotechnologyDietary SupplementsHealth Care
Series AJul 26, 2011
Amount Raised: $2,899,891
Q Chip

Cardiff, Cardiff, United Kingdom

Q Chip develops a range of sustained-release biogeneric and biotherapies products.

BiotechnologyLife ScienceTherapeutics
Series CMay 20, 2011
Amount Raised: $6,000,000
ACS Biomarker

Amsterdam, Noord-Holland, The Netherlands

ACS Biomarker is an emerging biomarker development company aiming to discover and develop biomarkers that improve prognosis and management

Biotechnology
Series UnknownMay 20, 2011
Nano4Imaging

Düsseldorf, Nordrhein-Westfalen, Germany

Nano4Imaging produces and uses medical devices and implants visible for medical interventions to monitor their function (e.g under MRI).

Health CareMedicalMedical Device
Series UnknownFeb 8, 2011